About Shalina Laboratories Private Limited
Data last updated:
Shalina Laboratories Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Shalina Healthcare Limited, Mauritius. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33100MH2020FTC344984. Its GSTIN is 27ABECS3337C1ZK (Maharashtra).
The company has an authorised share capital of ₹320 Cr and a paid-up capital of ₹82.76 Cr. It was formerly known as Shalina Healthcare Private Limited. It is led by directors including Prasad Shyamsunder Deshpande and Shalina Clifford.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 96 Maker Chamber VI Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹544.47 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹22.18 Cr (net margin 4.1%) and EBITDA of ₹42.23 Cr (EBITDA margin 7.8%).
The company has about 286 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹53 Cr on record. Court records list 62 cases involving the company, including 59 filed by the company and 3 filed against it; 30 cases are pending.
For more details, the company can be reached via its website shalina.com.
Company details
Contact details
Shalina Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is shalina.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address96 Maker Chamber VI Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shalina Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Shalina Laboratories are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shalina Laboratories Private Limited, buy the company report.
Financials of Shalina Laboratories Private Limited
FY 2025 filings availableShalina Laboratories Private Limited reported revenue of ₹544.47 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year. EBITDA fell 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shalina Laboratories Private Limited, buy the company report.
Board of directors of Shalina Laboratories Private Limited
Shalina Laboratories has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sundar Sankaran Also directs: Shalina Pharmaceuticals Private Limited, Shalina Trading Co Pvt Ltd, NJ Trustee Private Limited and 1 more | Nominee Director | 31 Aug 2020 | 6 Years 1 Months | Current |
| Prasad Shyamsunder Deshpande | Director | 02 Feb 2024 | 2 Years 8 Months | Current |
| Shalina Clifford Also directs: Shalina Pharmaceuticals Private Limited | Director | 17 Dec 2020 | 5 Years 10 Months | Current |
| Fazle Abbas Virji Also directs: Shalina Pharmaceuticals Private Limited | Director | 17 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Shalina Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Natural Remedies Private Limited | ₹548.65 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India | |||
| German Remedies Pharmaceuticals Private Limited | ₹546.98 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Gee Gee Kay Private Limited | ₹546.46 Cr (FY 2024) | -21.0% | Chennai, Tamil Nadu, India | |||
| Modulus Cosmetics Private Limited | ₹546.32 Cr (FY 2025) | -7.0% | Chandigarh, India | |||
| Nitta Gelatin India Limited | ₹544.58 Cr (FY 2025) | 0.0% | Ernakulam, Kerala, India | |||
| Shalina Laboratories Private Limitedthis company | ₹544.47 Cr (FY 2025) | ₹22.18 Cr | 4.1% | -8.0% | Mumbai, Maharashtra, India | |
| Graviti Pharmaceuticals Private Limited | ₹543.75 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Palvi Industries Limited | ₹543.65 Cr (FY 2025) | 43.0% | Vadodara, Gujarat, India | |||
| Special Blasts Limited | ₹542.88 Cr (FY 2025) | -17.0% | Raipur, Chhattisgarh, India | |||
| Ivp Ltd | ₹542.57 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Fairchem Organics Limited | ₹539.24 Cr (FY 2025) | -13.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Shalina Laboratories Private Limited, buy the company report.
Auditor
Shalina Laboratories Private Limited is audited by S R B C & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2023 | 324982E/E300003 |
Shareholding
The shareholding of Shalina Laboratories Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Shalina Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2022 | 100605031 | Others | ₹35 Cr | Open | |
| 05 Feb 2008 | 10095043 | Bank of India | ₹18 Cr | Open |
To see the full charge records of Shalina Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Shalina Laboratories Private Limited has 62 court cases on record: 59 filed by Shalina Laboratories, 3 filed against it. 30 cases are pending and 32 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 45 | 2 | 25 |
| District courts | 14 | 0 | 4 |
| NCLT | 2 | 0 | 0 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 62)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed by the company against Ardor Drugs Pvt. Ltd. and 2 others | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against Metallurgy Research LLP and 2 others | Pending |
| High Court | Court case (COMIP) | Filed by the company against Ardor Drugs Pvt. Ltd. and 2 others | Pending |
| High Court | Court case (COMIP) | Filed by the company against Metallurgy Research LLP and 2 others | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed by the company against Empree Medicaments India Pvt Ltd | Pending |
To see the full case history of Shalina Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Shalina Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 2,084 overdue payments to 141 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 141)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Manisha Analytical Laboratories Private Limited | |||
| an individual supplier | |||
| Supharma Chem | |||
| Skyline Corrogating Industries | |||
| Lifon Industries |
To see the full MSME payment records of Shalina Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Shalina Laboratories has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Shalina Pharmaceuticals Private Limited | U24299MH2021PTC364251 |
To see the full group structure of Shalina Laboratories Private Limited, buy the company report.
GST
Shalina Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABECS3337C1ZK | Maharashtra | Active | 09 Feb 2024 |
To see the full GST registrations and return filing status of Shalina Laboratories Private Limited, buy the company report.
Recent activity
Shalina Laboratories Private Limited has 10 board changes on record since 2020: 5 appointments and 5 cessations. The latest: Prasad Shyamsunder Deshpande ceased to be Additional Director on 27 Sep 2024.
5 earlier events are in the company report.
Frequently asked questions
Shalina Laboratories is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 August 2020 (6+ years old) and is registered under CIN U33100MH2020FTC344984.
Shalina Laboratories has 4 current directors:
- Sundar Sankaran - Nominee Director
- Prasad Shyamsunder Deshpande - Director
- Shalina Clifford - Director
- Fazle Abbas Virji - Director
The latest financial statements of Shalina Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Shalina Laboratories is 27ABECS3337C1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Shalina Laboratories is U33100MH2020FTC344984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shalina Laboratories has 62 court cases on record: 59 filed by the company and 3 filed against it. 30 are pending. Most are in the high courts.
Shalina Laboratories was incorporated on 31 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Shalina Laboratories by revenue are Natural Remedies Private Limited, German Remedies Pharmaceuticals Private Limited, Gee Gee Kay Private Limited, Modulus Cosmetics Private Limited, Nitta Gelatin India Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prasad Shyamsunder Deshpande ceased to be Additional Director on 27 Sep 2024. Prasad Shyamsunder Deshpande was appointed as Director on 02 Feb 2024. Sushil Kumar Agarwal was appointed as Company Secretary on 02 Feb 2024. Shalina Laboratories has 10 board changes on record in total.
Shalina Laboratories has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 2,084 overdue payments to 141 micro and small suppliers. The latest return was filed on 26 Apr 2024.
Shalina Laboratories can be reached through the website shalina.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Shalina Laboratories is at 96 Maker Chamber VI Nariman Point, Mumbai, Maharashtra, India – 400021.